<\/p>\n\n\n\n
Manavgat \u0130l\u00e7e Sa\u011fl\u0131k M\u00fcd\u00fcrl\u00fc\u011f\u00fc Kanser Birimi 1-31 Mart KOLOREKTAL (kal\u0131n ba\u011f\u0131rsak kanseri) fark\u0131ndal\u0131k ay\u0131 e\u011fitimlerine vergi dairesi personelleriyle ba\u015flad\u0131.<\/p>\n\n\n\n
KOLOREKTAL (Kal\u0131n ba\u011f\u0131rsak) Kanseri Fark\u0131ndal\u0131k Ay\u0131<\/p>\n\n\n\n
Her y\u0131l Mart ay\u0131 boyunca 81 ilimizde; Kal\u0131n ba\u011f\u0131rsak(Kolorektal) kanseri fark\u0131ndal\u0131\u011f\u0131n\u0131 art\u0131rmak, kal\u0131n ba\u011f\u0131rsak kanseri taramas\u0131n\u0131n \u00f6nemini vurgulamak ve ki\u015finin kal\u0131n ba\u011f\u0131rsak, rektum veya an\u00fcs kanserine yakalanma riskini azaltabilecek sa\u011fl\u0131kl\u0131 ya\u015fam tarz\u0131 al\u0131\u015fkanl\u0131klar\u0131n\u0131 te\u015fvik etmek i\u00e7in \u00e7e\u015fitli etkinlikler ger\u00e7ekle\u015ftirilmektedir.<\/p>\n\n\n\n
Sa\u011fl\u0131k konusunda bilin\u00e7lendirme ve fark\u0131ndal\u0131k kampanyalar\u0131 kapsam\u0131nda, \u201cKal\u0131n Ba\u011f\u0131rsak Kanseri Fark\u0131ndal\u0131k Ay\u0131\u201d \u00f6nemli bir giri\u015fim olarak \u00f6ne \u00e7\u0131kmaktad\u0131r. Kal\u0131n ba\u011f\u0131rsak kanseri \u00e7ok say\u0131da ya\u015fam\u0131 etkilemekte, erken te\u015fhis ve e\u011fitimi \u00e7ok \u00f6nemli k\u0131lmaktad\u0131r. Bu ay, sa\u011fl\u0131\u011f\u0131m\u0131za \u00f6ncelik vermemiz, taramalar\u0131n ve \u00f6nleyici tedbirlerin \u00f6nemini duyurmam\u0131z i\u00e7in bir f\u0131rsat olarak g\u00f6r\u00fclmektedir. Mart ay\u0131, kal\u0131n ba\u011f\u0131rsak kanserine y\u00f6nelik, \u00f6nleme, erken te\u015fhis ve tedavi se\u00e7eneklerini vurgulayarak, d\u00fczenli fark\u0131ndal\u0131k faaliyetlerinin \u00f6nemini ifade etmenin, erken te\u015fhisle kurtar\u0131lan hayatlar\u0131n gayreti i\u00e7inde s\u00fcrekli ara\u015ft\u0131rma ve e\u011fitim i\u00e7in bir araya gelmenin zaman\u0131d\u0131r.<\/p>\n\n\n\n
Kal\u0131n ba\u011f\u0131rsak kanserleri d\u00fcnyada ve \u00fclkemizde yayg\u0131n g\u00f6r\u00fclen kanser t\u00fcrleri aras\u0131nda yer almaktad\u0131r. D\u00fcnya \u00e7ap\u0131nda bir y\u0131l i\u00e7erisinde 1,9 milyon (%9,6) yeni kal\u0131n ba\u011f\u0131rsak kanseri vakas\u0131 ve 903 bin (%9,3) kal\u0131n ba\u011f\u0131rsak kanseri kaynakl\u0131 \u00f6l\u00fcm vakas\u0131 tespit edilmi\u015ftir.<\/p>\n\n\n\n
Avrupa, Kuzey Amerika, Rusya Avustralya ve Yeni Zelanda ‘da g\u00f6r\u00fclme s\u0131kl\u0131\u011f\u0131 Asya ve Afrika b\u00f6lgelerine g\u00f6re daha y\u00fcksektir. Bu co\u011frafi farkl\u0131l\u0131\u011f\u0131n \u00f6nemli etkenlerinin; beslenme tarz\u0131, \u00e7evresel maruziyet ve genetik yatk\u0131nl\u0131k oldu\u011fu d\u00fc\u015f\u00fcn\u00fclmektedir. 40 ya\u015f\u0131n alt\u0131nda kal\u0131n ba\u011f\u0131rsak kanseri nadirken, 40-50 ya\u015ftan sonra g\u00f6r\u00fclme s\u0131kl\u0131\u011f\u0131 artmaya ba\u015flamaktad\u0131r. Kal\u0131n ba\u011f\u0131rsak kanseri vakalar\u0131n\u0131n %85\u2019i 50 ya\u015f ve \u00fczerindedir.<\/p>\n\n\n\n
T\u00fcrkiye Birle\u015fik Veri Taban\u0131na g\u00f6re, \u00fclkemizde bu kanser t\u00fcrleri hem erkeklerde hem de kad\u0131nlarda 3. s\u0131rada yer almaktad\u0131r. Erkeklerde g\u00f6r\u00fclme s\u0131kl\u0131\u011f\u0131 y\u00fcz binde 25,5 kad\u0131nlarda ise 15,0 d\u0131r. Bir y\u0131lda yakla\u015f\u0131k 20 bin ki\u015fi kal\u0131n ba\u011f\u0131rsak kanseri tan\u0131s\u0131 almaktad\u0131r. Kal\u0131n ba\u011f\u0131rsak kanseri evreleri incelendi\u011finde vakalar\u0131n %20,9\u2019unun uzak evrede oldu\u011fu g\u00f6r\u00fclmektedir.<\/p>\n\n\n\n
Erken evrede te\u015fhis edildi\u011finde b\u00fcy\u00fck \u00f6l\u00e7\u00fcde tedavi edilebilir bir hastal\u0131k olan kal\u0131n ba\u011f\u0131rsak kanserlerinde tarama programlar\u0131n\u0131n uygulanmas\u0131 ile s\u00f6z konusu hastal\u0131\u011f\u0131n g\u00f6r\u00fclme s\u0131kl\u0131\u011f\u0131 ve \u00f6l\u00fcm oran\u0131 \u00fczerinde \u00e7ok olumlu kazan\u0131mlar sa\u011fland\u0131\u011f\u0131 yap\u0131lan bir\u00e7ok \u00e7al\u0131\u015fma ile ortaya konmu\u015ftur.<\/p>\n\n\n\n
Kal\u0131n ba\u011f\u0131rsak kanserlerinin taranmas\u0131ndaki temel ama\u00e7; \u00fclke \u00e7ap\u0131nda olu\u015fturulan ulusal bir tarama program\u0131n\u0131 hedef pop\u00fclasyona uygulayarak kal\u0131n ba\u011f\u0131rsak patolojilerini hen\u00fcz kanser \u00f6ncesi d\u00f6nemde erken evrede tespit etmenin yan\u0131 s\u0131ra etkin ve basit tedavi y\u00f6ntemleriyle invaziv kanser s\u0131kl\u0131\u011f\u0131 ile buna ba\u011fl\u0131 morbidite ve mortaliteyi azaltmakt\u0131r. Bu yolla olas\u0131 karma\u015f\u0131k ve pahal\u0131 tedavi gereksinimlerinin de \u00f6nlenmesi hedeflenmektedir. Gerek ya\u015fam kalitesini artt\u0131rd\u0131\u011f\u0131 gerekse ya\u015fam s\u00fcresini uzatt\u0131\u011f\u0131 bilindi\u011finden, kal\u0131n ba\u011f\u0131rsak tarama program\u0131 D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc taraf\u0131ndan \u00f6nerilen kanser tarama programlar\u0131 i\u00e7erisinde yer almaktad\u0131r.<\/p>\n\n\n\n
\u00dclkemizde de Kal\u0131n Ba\u011f\u0131rsak Kanseri Taramas\u0131 Ulusal Standartlar\u0131 belirlenerek uygulamaya konulmu\u015ftur. 50-70 ya\u015f aras\u0131ndaki kad\u0131n ve erkek n\u00fcfusa Toplum Sa\u011fl\u0131\u011f\u0131 Merkezlerine (TSM) ba\u011fl\u0131 olarak faaliyet g\u00f6stermekte olan; Kanser Erken Te\u015fhis, Tarama ve E\u011fitim Merkezleri (KETEM), Sa\u011fl\u0131kl\u0131 Hayat Merkezleri (SHM) ve Aile Sa\u011fl\u0131\u011f\u0131 Merkezleri (ASM)\u2019nde Gaitada Gizli Kan kiti yard\u0131m\u0131yla h\u0131zl\u0131, pratik ve g\u00fcvenilir bir \u015fekilde 2 y\u0131lda bir \u00fccretsiz olarak tarama yap\u0131lmaktad\u0131r. Tarama kapsam\u0131nda bu ya\u015f grubundaki ki\u015filere ayr\u0131ca 10 y\u0131lda bir kolonoskopi yap\u0131lmas\u0131 \u00f6nerilmektedir. Tarama sonucunda Gaitada Gizli Kan Testi (GGKT) pozitif olan ki\u015filer ileri tetkik amac\u0131yla ikinci\/\u00fc\u00e7\u00fcnc\u00fc basamak sa\u011fl\u0131k kurulu\u015flar\u0131na y\u00f6nlendirilmektedir.<\/p>\n\n\n\n
Kal\u0131n Ba\u011f\u0131rsak Kanseri Risk Fakt\u00f6rleri<\/p>\n\n\n\n
Kal\u0131n ba\u011f\u0131rsak geli\u015fme riski hem \u00e7evresel hem de genetik fakt\u00f6rlerden kaynaklan\u0131r.<\/p>\n\n\n\n
Kal\u0131n ba\u011f\u0131rsak kanserinin de\u011fi\u015ftirilebilir risk fakt\u00f6rleri \u015funlar\u0131 i\u00e7ermektedir:<\/p>\n\n\n\n
A\u015f\u0131r\u0131 kilolu veya obez olmak (D\u00fcnyada bir y\u0131lda ortalama 110 bin vakan\u0131n obeziteye ba\u011fl\u0131 ger\u00e7ekle\u015fti\u011fi tahmin edilmektedir.)<\/p>\n\n\n\n
Fiziksel olarak aktif olmamak<\/p>\n\n\n\n
Fazla miktarda i\u015flenmi\u015f (sosis, salam ve benzeri) veya i\u015flenmemi\u015f k\u0131rm\u0131z\u0131 et (s\u0131\u011f\u0131r, kuzu, karaci\u011fer ve benzerleri) t\u00fcketimi<\/p>\n\n\n\n
T\u00fct\u00fcn ve t\u00fct\u00fcn \u00fcr\u00fcnlerinin kullan\u0131m\u0131<\/p>\n\n\n\n
Alkol kullan\u0131m\u0131 (D\u00fcnyada bir y\u0131lda ortalama 160 bin vakan\u0131n alkol kullan\u0131m\u0131na ba\u011fl\u0131 ger\u00e7ekle\u015fti\u011fi tahmin edilmektedir.)<\/p>\n\n\n\n
Diyabet ve ins\u00fclin direnci varl\u0131\u011f\u0131<\/p>\n\n\n\n
Kolesistektomi<\/p>\n\n\n\n
Kal\u0131n ba\u011f\u0131rsak kanserinin de\u011fi\u015ftirilemez risk fakt\u00f6rleri aras\u0131nda ise \u015funlar yer almaktad\u0131r:<\/p>\n\n\n\n
Cinsiyet (hem insidans hem de \u00f6l\u00fcm oranlar\u0131 erkeklerde kad\u0131nlara g\u00f6re \u00f6nemli \u00f6l\u00e7\u00fcde daha y\u00fcksektir.)<\/p>\n\n\n\n
\u0130leri ya\u015f<\/p>\n\n\n\n
Irk ve etnik k\u00f6ken<\/p>\n\n\n\n
Ki\u015fide kal\u0131n ba\u011f\u0131rsak poliplerinin veya kal\u0131n ba\u011f\u0131rsak kanseri \u00f6yk\u00fcs\u00fcn\u00fcn bulunmas\u0131<\/p>\n\n\n\n
Ki\u015fide inflamatuvar ba\u011f\u0131rsak hastal\u0131\u011f\u0131 (\u00dclseratif kolit veya Crohn hastal\u0131\u011f\u0131) \u00f6yk\u00fcs\u00fcn\u00fcn varl\u0131\u011f\u0131<\/p>\n\n\n\n
Ailede kal\u0131n ba\u011f\u0131rsak polipleri veya kal\u0131n ba\u011f\u0131rsak kanseri \u00f6yk\u00fcs\u00fcn\u00fcn olmas\u0131<\/p>\n\n\n\n
Kal\u0131tsal bir sendromun varl\u0131\u011f\u0131 (Lynch Sendromu, adenomat\u00f6z ve hamartomat\u00f6z polipozis sendromlar\u0131 vb)<\/p>\n\n\n\n
Tip 2 diyabet hastas\u0131 olunmas\u0131<\/p>\n\n\n\n
Akromegali varl\u0131\u011f\u0131<\/p>\n\n\n\n
B\u00f6brek transplantasyonu ge\u00e7irmi\u015f olmak<\/p>\n\n\n\n
Androjen yoksunlu\u011fu tedavisi alm\u0131\u015f olmak<\/p>\n\n\n\n
Kistik fibrozis varl\u0131\u011f\u0131<\/p>\n\n\n\n
Abdominopelvik radyasyon \u00f6yk\u00fcs\u00fcn\u00fcn olmas\u0131.<\/p>\n\n\n\n
Kal\u0131n Ba\u011f\u0131rsak Kanseri Belirtileri<\/p>\n\n\n\n
Kal\u0131n ba\u011f\u0131rsak kanseri, t\u00fcm\u00f6r\u00fcn bulundu\u011fu ba\u011f\u0131rsak b\u00f6lgesine g\u00f6re farkl\u0131 belirtiler g\u00f6sterebilir fakat hi\u00e7bir belirti vermeden de olu\u015fabilir. Belirti g\u00f6stermesi durumunda bulundu\u011fu b\u00f6lgeye g\u00f6re farkl\u0131 \u015fikayetlere sebep olur. Belirtilerin silik olmas\u0131, sinsi ilerleyi\u015fi sebebiyle tarama programlar\u0131 \u00f6zellikle \u00f6nem arz eder.<\/p>\n\n\n\n
T\u00fcm g\u00f6r\u00fclebilecek belirtiler genel olarak \u015funlard\u0131r:<\/p>\n\n\n\n
Ba\u011f\u0131rsak al\u0131\u015fkanl\u0131klar\u0131nda ishal-kab\u0131zl\u0131k gibi de\u011fi\u015fikliklerin meydana gelmesi ve bu de\u011fi\u015fikliklerin birka\u00e7 g\u00fcnden uzun s\u00fcrmesi<\/p>\n\n\n\n
Ba\u011f\u0131rsakta tam bo\u015falmama hissi<\/p>\n\n\n\n
Parlak ya da koyu k\u0131rm\u0131z\u0131 kanla karakterize rektal kanama<\/p>\n\n\n\n
D\u0131\u015fk\u0131n\u0131n koyu kahverengi veya siyah g\u00f6r\u00fcnmesine neden olabilecek kan\u0131n varl\u0131\u011f\u0131<\/p>\n\n\n\n
Kar\u0131nda \u015fi\u015fkinlik, kramp tarz\u0131nda a\u011fr\u0131 veya gaz \u015fik\u00e2yeti<\/p>\n\n\n\n
Bilinen bir neden olmaks\u0131z\u0131n kilo kayb\u0131<\/p>\n\n\n\n
Kans\u0131zl\u0131k (Anemi), halsizlik, yorgunluk<\/p>\n\n\n\n
A\u011fr\u0131l\u0131 d\u0131\u015fk\u0131lama<\/p>\n\n\n\n
Kitle<\/p>\n\n\n\n
Kal\u0131n Ba\u011f\u0131rsak Kanseri Tan\u0131s\u0131<\/p>\n\n\n\n
Di\u011fer baz\u0131 kanserlerde oldu\u011fu gibi Kal\u0131n ba\u011f\u0131rsak kanserleri de genellikle iyice b\u00fcy\u00fcyene kadar belirti vermezler. Bu sebeple ama\u00e7, daha belirti vermezken t\u00fcm\u00f6r\u00fc ortaya koymak olmal\u0131d\u0131r. Belirtiler geli\u015fmeden \u00f6nce bir ki\u015finin kanser i\u00e7in taranmas\u0131, poliplerin ve kanserin erken tan\u0131nmas\u0131nda yard\u0131mc\u0131 olur. Poliplerin erkenden tan\u0131n\u0131p \u00e7\u0131kart\u0131lmas\u0131 kolorektal kanser geli\u015fimini \u00f6nleyebilir. Erken tan\u0131 konuldu\u011funda kolorektal kanserin tedavisi de daha etkin olabilmektedir. Bu nedenle, genel olarak 50 ya\u015f \u00fcst\u00fc ki\u015filerde taramaya ba\u015flanmal\u0131, kolorektal kanser i\u00e7in artm\u0131\u015f riski olan ki\u015filerde ise tarama program\u0131na daha erken ya\u015flarda ba\u015flanmal\u0131d\u0131r.<\/p>\n\n\n\n
D\u0131\u015fk\u0131da gizli kan saptan\u0131p kolonoskopi yap\u0131lan ki\u015filerde hen\u00fcz kanserle\u015fmemi\u015f polip halindeki t\u00fcm\u00f6rler tespit edilerek kanser geli\u015fmesi \u00f6nlenebildi\u011fi gibi kanser geli\u015fmi\u015f olan olgularda da erken te\u015fhis ile ya\u015fam s\u00fcresi ve kalitesi artmaktad\u0131r.<\/p>\n\n\n\n
Kal\u0131n Ba\u011f\u0131rsak Kanseri Tedavisi<\/p>\n\n\n\n
Erken evre Kal\u0131n ba\u011f\u0131rsak kanserinin temel tedavisi cerrahi giri\u015fimdir. Kal\u0131n ba\u011f\u0131rsak kanseri tedavisinde “kolektomi” ad\u0131 verilen cerrahi i\u015flem uygulan\u0131r. Kolektomi, kal\u0131n ba\u011f\u0131rsa\u011f\u0131n bir k\u0131sm\u0131n\u0131n ameliyatla \u00e7\u0131kar\u0131lmas\u0131 anlam\u0131na gelmektedir. T\u00fcm\u00f6r i\u00e7eren ba\u011f\u0131rsak b\u00f6l\u00fcm\u00fc ve bu b\u00f6l\u00fcme kom\u015fu lenf bezleri bu i\u015flemde \u00e7\u0131kar\u0131lmaktad\u0131r.<\/p>\n\n\n\n
Kal\u0131n ba\u011f\u0131rsak kanserinin tedavisinde hastal\u0131\u011f\u0131n evresine g\u00f6re kemoterapi, Radyoterapi hedefe y\u00f6nelik ila\u00e7lar ve immunoterapi se\u00e7enekleri mevcuttur.<\/p>\n\n\n\n
Kal\u0131n Ba\u011f\u0131rsak Kanserinden Korunma Stratejileri<\/p>\n\n\n\n
Kal\u0131n ba\u011f\u0131rsak kanserini \u00f6nlemek i\u00e7in at\u0131lmas\u0131 gereken en \u00f6nemli ad\u0131mlardan biri tarama program\u0131 olmakla birlikte, a\u015fa\u011f\u0131daki sa\u011fl\u0131kl\u0131 ya\u015fam davran\u0131\u015flar\u0131n\u0131 uygulamak da di\u011fer bir\u00e7ok kanserden oldu\u011fu gibi kolorektal kanserlerden korunmada \u00f6nemlidir:<\/p>\n\n\n\n
Sa\u011fl\u0131kl\u0131 kiloda olmak ve bunu s\u00fcrd\u00fcrmek<\/p>\n\n\n\n
K\u0131rm\u0131z\u0131 ve i\u015flenmi\u015f et t\u00fcketimini s\u0131n\u0131rland\u0131rmak ve daha fazla taze sebze, meyve ve tam tah\u0131l \u00fcr\u00fcn\u00fc t\u00fcketmek.<\/p>\n\n\n\n
Posa i\u00e7eri\u011fi y\u00fcksek besinlerin t\u00fcketimini art\u0131rmak. (Posa i\u00e7eri\u011fi en y\u00fcksek besinler s\u0131ras\u0131yla; kuru baklagiller, tah\u0131llar ve sebze-meyvelerdir.)<\/p>\n\n\n\n
G\u00fcnde 30-60 dakika orta d\u00fczeyde fiziksel aktivite yapmak (tempolu y\u00fcr\u00fcy\u00fc\u015f, bisiklete binmek gibi)<\/p>\n\n\n\n
Sigara ve alkol kullanmamak.<\/p>\n\n\n\n
Mart ay\u0131 Kal\u0131n Ba\u011f\u0131rsak Kanseri Fark\u0131ndal\u0131k Ay\u0131 olarak t\u00fcm d\u00fcnyada oldu\u011fu gibi \u00fclkemizde de \u00e7e\u015fitli etkinliklerle konuya ili\u015fkin fark\u0131ndal\u0131k faaliyetleri, umut, tedbir ve proaktif sa\u011fl\u0131k \u00f6nlemleri mesajlar\u0131yla halka \u0131\u015f\u0131k tutacak \u00e7al\u0131\u015fmalar y\u00fcr\u00fct\u00fclmektedir.<\/p>\n\n\n\n
Bu \u00f6nemli fark\u0131ndal\u0131k ay\u0131n\u0131n bir par\u00e7as\u0131 olmak i\u00e7in a\u015fa\u011f\u0131daki unsurlara dikkat edilmelidir:<\/p>\n\n\n\n
Taraman\u0131z\u0131 yapt\u0131r\u0131n: Uygunsan\u0131z veya risk alt\u0131ndaysan\u0131z, Kal\u0131n ba\u011f\u0131rsak kanseri taramas\u0131 yapt\u0131rmaya \u00f6ncelik verin. Sevdiklerinizi de ayn\u0131s\u0131n\u0131 yapmaya te\u015fvik edin.<\/p>\n\n\n\n
Mavi Giyin: Deste\u011finizi g\u00f6stermek ve ileti\u015fimi g\u00f6r\u00fcn\u00fcr k\u0131lmak i\u00e7in \u00f6zellikle mavi rengi giysilerinizde veya uygun buldu\u011funuz \u015fekilde kullan\u0131n.<\/p>\n\n\n\n
Etkinliklere Kat\u0131l\u0131n: Kal\u0131n ba\u011f\u0131rsak kanseri fark\u0131ndal\u0131\u011f\u0131na y\u00f6nelik e\u011fitimlere, seminerlere ve yerel etkinliklere kat\u0131l\u0131n veya bunlar\u0131 d\u00fczenleyin.<\/p>\n\n\n\n
Hik\u00e2yeleri Payla\u015f\u0131n: Siz veya tan\u0131d\u0131\u011f\u0131n\u0131z biri Kal\u0131n ba\u011f\u0131rsak kanserinden etkilendiyse, deneyimlerinizi payla\u015fmak ba\u015fkalar\u0131 i\u00e7in e\u011fitici ve hayatlar\u0131n\u0131 kolayla\u015ft\u0131r\u0131c\u0131 katk\u0131 sa\u011flayabilir.<\/p>\n\n\n\n
Bu kapsamda kal\u0131n ba\u011f\u0131rsak kanseri fark\u0131ndal\u0131k ay\u0131 i\u00e7in 2024 y\u0131l\u0131 temalar\u0131;<\/p>\n\n\n\n
\u2018\u2019Kal\u0131n Ba\u011f\u0131rsak Kanserinden Korunmak Sizin Elinizde;<\/p>\n\n\n\n
Sa\u011fl\u0131kl\u0131 beslenin,<\/p>\n\n\n\n
Egzersiz yap\u0131n,<\/p>\n\n\n\n
Tarama Testlerinizi \u0130hmal Etmeyin.\u2019\u2019<\/p>\n\n\n\n
Kal\u0131n ba\u011f\u0131rsak kanserinden \u00f6nce, sa\u011fl\u0131\u011f\u0131n\u0131z i\u00e7in test yapt\u0131r\u0131n.<\/p>\n\n\n\n
Kal\u0131n ba\u011f\u0131rsak kanseri i\u00e7in en \u00f6nemli risk; taramay\u0131 ertelemektir!<\/p>\n\n\n\n
Kal\u0131n ba\u011f\u0131rsak kanseri \u00e7ok yava\u015f ilerledi\u011fi i\u00e7in kanser \u00f6ncesi olu\u015fumlar\u0131 tarama ile saptamak m\u00fcmk\u00fcnd\u00fcr.<\/p>\n\n\n\n
Tarama, kanser \u00f6ncesi poliplerin saptanmas\u0131 ve \u00e7\u0131kar\u0131lmas\u0131 ile sizi kal\u0131n ba\u011f\u0131rsak kanserinden korur!<\/p>\n\n\n\n
Ailenizden hi\u00e7 kimsede kal\u0131n ba\u011f\u0131rsak kanseri olmamas\u0131, kolonoskopiden ka\u00e7\u0131nma mazeretiniz olmas\u0131n! \u0130lk kez sizde olup olmad\u0131\u011f\u0131n\u0131 ancak tarama yapt\u0131rarak \u00f6\u011frenebilirsiniz.<\/p>\n\n\n\n
Kal\u0131n ba\u011f\u0131rsak kanseri sadece erkeklerin hastal\u0131\u011f\u0131 de\u011fildir! Cinsiyet se\u00e7mez! \u00d6\u011frenmenin tek yolu d\u00fczenli tarama yapt\u0131rmakt\u0131r.<\/p>\n\n\n\n
Haber Merkezi<\/p>\n","protected":false},"excerpt":{"rendered":"
Manavgat \u0130l\u00e7e Sa\u011fl\u0131k M\u00fcd\u00fcrl\u00fc\u011f\u00fc Kanser Birimi 1-31 Mart KOLOREKTAL (kal\u0131n ba\u011f\u0131rsak kanseri) fark\u0131ndal\u0131k ay\u0131 e\u011fitimlerine vergi dairesi personelleriyle ba\u015flad\u0131. KOLOREKTAL (Kal\u0131n ba\u011f\u0131rsak) Kanseri Fark\u0131ndal\u0131k Ay\u0131 [more…]<\/a><\/p>\n","protected":false},"author":2,"featured_media":21085,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"class_list":["post-21084","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-gundem"],"_links":{"self":[{"href":"https:\/\/akdenizhaber.com.tr\/index.php\/wp-json\/wp\/v2\/posts\/21084","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/akdenizhaber.com.tr\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/akdenizhaber.com.tr\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/akdenizhaber.com.tr\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/akdenizhaber.com.tr\/index.php\/wp-json\/wp\/v2\/comments?post=21084"}],"version-history":[{"count":0,"href":"https:\/\/akdenizhaber.com.tr\/index.php\/wp-json\/wp\/v2\/posts\/21084\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/akdenizhaber.com.tr\/index.php\/wp-json\/wp\/v2\/media\/21085"}],"wp:attachment":[{"href":"https:\/\/akdenizhaber.com.tr\/index.php\/wp-json\/wp\/v2\/media?parent=21084"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/akdenizhaber.com.tr\/index.php\/wp-json\/wp\/v2\/categories?post=21084"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/akdenizhaber.com.tr\/index.php\/wp-json\/wp\/v2\/tags?post=21084"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}